These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21397310)

  • 1. Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion.
    Rachid R; Castells M; Cunningham-Rundles C; Bonilla FA
    J Allergy Clin Immunol; 2011 Jul; 128(1):228-230.e1. PubMed ID: 21397310
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature.
    Rachid R; Bonilla FA
    J Allergy Clin Immunol; 2012 Mar; 129(3):628-34. PubMed ID: 21835445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is there any clinical significance to anti-IgA antibodies which appear in patients with immunodeficiencies treated with intravenous gamma globulin?].
    Ferreira A; Cruz García Rodríguez M; Martín J; Fontán G
    Sangre (Barc); 1995 Jun; 40(3):171-3. PubMed ID: 7570266
    [No Abstract]   [Full Text] [Related]  

  • 4. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy.
    de Albuquerque Campos R; Sato MN; da Silva Duarte AJ
    J Clin Immunol; 2000 Jan; 20(1):77-82. PubMed ID: 10798611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of anti-IgA antibodies in primary immunodeficient patients treated with gamma-globulin.
    Ferreira A; García Rodriguez MC; Fontán G
    Vox Sang; 1989; 56(4):218-22. PubMed ID: 2474899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG anti-IgA antibodies in paediatric antibody-deficient patients receiving intravenous immunoglobulin.
    Torabi Sagvand B; Mirminachi B; Abolhassani H; Shokouhfar T; Keihanian T; Amirzargar A; Mahdaviani A; Aghamohammadi A
    Allergol Immunopathol (Madr); 2015; 43(4):403-8. PubMed ID: 25201762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin.
    Frankel SJ; Polmar SH; Grumet FC; Wedner HJ
    Ann Allergy; 1986 May; 56(5):436-9. PubMed ID: 2422990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin.
    Ferreira A; Garcia Rodriguez MC; Lopez-Trascasa M; Pascual Salcedo D; Fontan G
    Clin Immunol Immunopathol; 1988 May; 47(2):199-207. PubMed ID: 2450712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody.
    Cunningham-Rundles C; Wong S; Björkander J; Hanson LA
    Clin Immunol Immunopathol; 1986 Feb; 38(2):141-9. PubMed ID: 3079685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency.
    Klartag A; Chen CC; Dougherty JP; Ron Y
    Autoimmunity; 2010 Mar; 43(2):164-71. PubMed ID: 19824874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin replacement therapy: is there a role for IgA and IgM?
    Kiani-Alikhan S; Yong PF; Grosse-Kreul D; Elston C; Ibrahim MA
    J Allergy Clin Immunol; 2012 Aug; 130(2):553-4; author reply 554. PubMed ID: 22664164
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of intravenous immunoglobulin.
    Thornton CA; Ballow M
    Arch Neurol; 1993 Feb; 50(2):135-6. PubMed ID: 8431130
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment.
    Ahrens N; Höflich C; Bombard S; Lochs H; Kiesewetter H; Salama A
    Clin Exp Immunol; 2008 Mar; 151(3):455-8. PubMed ID: 18234056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
    Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B
    Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusing patients with anti-immunoglobulin A subclass antibodies.
    Gilstad CW; Kessler C; Sandler SG
    Vox Sang; 2002 Nov; 83(4):363. PubMed ID: 12437525
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful gamma globulin therapy in a patient with anti-IgA antibodies].
    Litzman J; Broz P; Král V; Lokaj J
    Vnitr Lek; 1997 Feb; 43(2):102-4. PubMed ID: 9245064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental IgA nephropathy in rabbits: effects of oral immunization in serum sickness nephritis].
    Koni I
    Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):9-21. PubMed ID: 2455086
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-immunoglobulin antibodies in immunologically deficient patients. Value of their determination in intolerance reactions to therapeutic gamma globulin injections].
    Caldera LH; Ropars C; Griscelli C; Homberg JC; Salmon C
    Rev Fr Transfus; 1973 Dec; 16(4):393-402. PubMed ID: 4135408
    [No Abstract]   [Full Text] [Related]  

  • 19. A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient.
    Tsujita Y; Imai K; Honma K; Kamae C; Horiuchi T; Nonoyama S
    J Clin Immunol; 2018 Jan; 38(1):144-148. PubMed ID: 29255996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgA screening and use of IVIG.
    Hunt AF; Reed MI
    Lancet; 1990 Nov; 336(8724):1197. PubMed ID: 1700247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.